The addition of radiation to chemotherapy did not improve overall survival in patients with locally advanced endometrial ...
Flow Space on MSN5d
Is Bleeding After Menopause Always Cancer? Here's What You Should KnowIf somebody has gone through menopause and then bleeding reappears, it’s really important that the patient does not make ...
The risk and incidence of cancer among people under 50 is also on the rise, according to American Cancer Society.
GSK’s Jemperli is designed to help the body’s immune system find and attack cancer cells, and is already approved in the EU ...
GSK's Jemperli wins EU approval for broader use in advanced endometrial cancer, showing improved survival and significant ...
Incidences for many common types of cancer have risen in recent years, with young women experiencing the brunt of the shift.
Meanwhile, J&J has claimed EU approval for its combination of EGFRxMET bispecific antibody Rybrevant (amivantamab) with third ...
European Commission approves GSK’s Jemperli plus chemotherapy to treat patients with primary advanced or recurrent endometrial cancer: London, UK Tuesday, January 21, 2025, 09:0 ...
High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback